CrushSCI.com
120.6平均天数
124中位天数
63最短天数
252最长天数
6272025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

72 天

Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020

作者
Hriday P. Bhambhvani; Gal Wald; Anjile An; Neal Patel; Daniel A. Barocas; Kevin H. Kensler; Myles M. Reed; David M. Nanus; Rulla Tamimi; Jonathan E. Shoag; Bashir Al Hussein Al Awamlh展开收起
作者单位
Department of Urology, Weill Cornell Medicine, New York, NY; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY; Department of Urology, Vanderbilt University Medical Center, Nashville, TN; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY; Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH展开收起
PDF源文件 DOI 网页
90 天

Second primary cancer risk after penile squamous cell carcinoma: A population-based study

作者
Hue T.T. Tran; Frank Z. Jing; Duc L. Van; Raslina Shrestha; Granville L. Lloyd; Clark C. Otley; Daniel S. Childs; Giang H. Nguyen展开收起
作者单位
Department of Dermatology, Mayo Clinic, Rochester, MN; Department of Surgery, Section of Urology, CU Anschutz School of Medicine, Aurora, CO; Department of Surgery, Section of Robotic Surgery, Rocky Mountain Regional VA Hospital, Aurora, CO; Division of Dermatology Surgery, Department of Dermatology, Mayo Clinic, Rochester, MN; Department of Medical Oncology, Mayo Clinic, Rochester, MN展开收起
PDF源文件 DOI 网页
145 天

Impact of divergent differentiation and histological subtypes on oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma

作者
Maximilian Pallauf; Stephan Brönimann; Sean A. Fletcher; Michael E. Rezaee; David J. McConkey; Aaron M. Potretzke; Stephen A. Boorjian; Morgan Rouprêt; Hooman Djaladat; Alireza Ghoreifi; Francesco Soria; Riccardo Campi; Salvatore Granata; Zine-Eddine Khene; Eiji Kikuchi; Michael Rink; Markus von Deimling; Kazutoshi Fujita; David D’Andrea; Shahrokh F. Shariat; Joost Boormans; Benjamin Pradere; Nirmish Singla展开收起
作者单位
The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Urology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Mayo Clinic, Rochester, MN; Department of Urology, Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Pitie-Salpetriere Hospital, Paris, France; Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA; Division of Urology, Department of Surgical Sciences, AOU città della Salute e della Scienza di Torino, Torino School of Medicine, Torino, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Department of Oncology, Unit of Urology and Renal Transplantation, Careggi University Hospital, Florence, Italy; Department of Urology, University of Rennes, Rennes, France; Department of Urology, St. Marianna University School of Medicine, Kanagawa, Japan; Department of Urology, Marienkrankenhaus Hamburg, Hamburg, Germany; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern, Dallas, TX; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Urology UROSUD, La Croix du Sud Hospital, Quint-Fonsegrives, France展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。